Viewing Study NCT04513860


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-01-07 @ 7:26 AM
Study NCT ID: NCT04513860
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2022-01-26
First Post: 2020-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cenobamate Expanded Access Program (EAP)
Sponsor: SK Life Science, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Partial Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Partial onset seizures View
None Treatment resistant View
None Partial epilepsy View